Who owns Context Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CNTX from SEC Form 13F filings across 79 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 79 institutions disclosed 62.8M shares of Context Therapeutics Inc. worth $34.8M — about 66% of shares outstanding; the largest disclosed holder is Nextech Invest Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
79
13F holders
$34.8M
value, 2026 filers
66%
of shares outstanding (62.8M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CNTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Nextech Invest Ltd. | 7.4M | $4.1M | 0.2% | 7.8% | 0.0% |
| 2 | Deep Track Capital, LP | 7.4M | $4.1M | 0.1% | 7.8% | 0.0% |
| 3 | Soleus Capital Management, L.P. | 7.1M | $3.9M | 0.1% | 7.4% | +1.4% |
| 4 | BlackRock, Inc. | 6.2M | $3.4M | 0.0% | 6.5% | +628.6% |
| 5 | Avidity Partners Management LP | 5.0M | $2.8M | 0.4% | 5.3% | 0.0% |
| 6 | FRANKLIN RESOURCES INC | 3.8M | $2.1M | 0.0% | 4% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4M | $1.9M | 0.0% | 3.6% | 0.0% |
| 8 | Octagon Capital Advisors LP | 3.0M | $1.7M | 0.2% | 3.2% | -41.9% |
| 9 | Blue Owl Capital Holdings LP | 2.9M | $1.6M | 0.2% | 3.1% | -42.3% |
| 10 | TCG Crossover Management, LLC | 2.7M | $1.5M | 0.0% | 2.8% | 0.0% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $1.0M | 0.0% | 1.9% | +203.1% |
| 12 | STATE STREET CORP | 1.4M | $782,898 | 0.0% | 1.5% | +505.3% |
| 13 | MPM BIOIMPACT LLC | 1.3M | $719,542 | 0.0% | 1.4% | -87.8% |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 1.0M | $576,831 | 0.0% | 1.1% | +469.1% |
| 15 | ACADIAN ASSET MANAGEMENT LLCNEW | 1.0M | $559,000 | 0.0% | 1.1% | new |
| 16 | ADAR1 Capital Management, LLC | 750,969 | $415,962 | 0.0% | 0.8% | +113.9% |
| 17 | JANE STREET GROUP, LLC | 645,209 | $357,382 | 0.0% | 0.7% | +47.7% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 638,878 | $353,938 | 0.0% | 0.7% | new |
| 19 | NORTHERN TRUST CORP | 615,576 | $340,967 | 0.0% | 0.6% | +496.2% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 433,888 | $240,374 | 0.0% | 0.5% | +27.1% |
| 21 | MARSHALL WACE, LLP | 384,528 | $211,490 | 0.0% | 0.4% | -87.0% |
| 22 | XTX Topco LtdNEW | 294,301 | $163,013 | 0.0% | 0.3% | new |
| 23 | Qube Research & Technologies Ltd | 257,068 | $142,390 | 0.0% | 0.3% | +2155.4% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW | 227,850 | $126,206 | 0.0% | 0.2% | new |
| 25 | Pathstone Holdings, LLC | 214,875 | $119,019 | 0.0% | 0.2% | +94.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.